sFlt-1/PlGF Ratio (Preeclampsia)
ورودیهای بالینی بیمار
حداقل ۱۰ — حداکثر ۱۰۰۰۰۰ • واحد: pg/mL
حداقل ۱ — حداکثر ۱۰۰۰۰ • واحد: pg/mL
حداقل ۲۰ — حداکثر ۴۳ • واحد: weeks
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–37.9
- Intermediate0–0
- High risk0–100000
The sFlt-1/PlGF Ratio (Preeclampsia) calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include sflt1. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
sFlt-1/PlGF ratio for preeclampsia risk stratification (PROGNOSIS): ratio <38 rules out preeclampsia within 1 week (NPV ~99%); ratio >85 before 34 weeks or >110 from 34 weeks indicates high risk and aids diagnosis. For suspected preeclampsia, not for low-risk screening.
Clinical Indication
The sFlt-1/PlGF Ratio (Preeclampsia) is indicated for bedside clinical practice to support sFlt-1/PlGF ratio for preeclampsia risk stratification (PROGNOSIS): ratio <38 rules out preeclampsia within 1 week (NPV ~99%); ratio >85 before 34 weeks or >110 from 34 weeks indicates high risk and aids diagnosis. For suspected preeclampsia, not for low-risk screening.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.
Limitations & Contraindications
Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.
Clinical Pearls & Action Plan
Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.
ratio = sFlt-1 / PlGF
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sflt1 | float | Yes | sFlt-1 concentration(pg/mL) |
| plgf | float | Yes | PlGF concentration(pg/mL) |
| ga_weeks | float | Yes | Gestational age in weeks(weeks) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–37.9 | Low risk | Low risk (<38) |
| 0–0 | Intermediate | Intermediate (38 to high cutoff) |
| 0–100000 | High risk | High risk |
Evidence-Based References (EBM)
- Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;375(1):63-64 (PROGNOSIS).